Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic basis of drug-induced arrhythmias.

Annals of medicine - 1 Jan 2004

Vos Marc A, Paulussen Aimée D C

Abstract excerpt

Drug-induced torsade de pointes arrhythmia (TdP) is frequently seen in patients. This proarrhythmia is not restricted to anti-arrhythmics but includes a variety of drugs. A genetic predisposition is an attractive explanation for this clinical problem. In this review, we: 1) explain the arrhythmogenic mechanisms of TdP, 2) provide data for a genetic cause based upon mutations in the long QT or in cytochrome genes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Arrhythmia Agents
Share to Arrhythmias, Cardiac
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electrocardiography

Share to Long QT Syndrome

Share to Sulfonamides

Share to Torsades de Pointes

Source

Identifiers

PMID: 15176422
DOI: 10.1080/17431380410032634

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic basis of drug-induced arrhythmias.PMID 15176422Read ↗

Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes.Semantic proximity Read ↗

The genetics of pro-arrhythmic adverse drug reactions.Semantic proximity Read ↗

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.Semantic proximity Read ↗

Drug-induced arrhythmia: pharmacogenomic prescribing?Semantic proximity Read ↗

Pharmacogenetics and drug-induced arrhythmiasSemantic proximity Read ↗

Genetic and Molecular Aspects of Drug-Induced QT Interval ProlongationSemantic proximity Read ↗

Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.Semantic proximity Read ↗

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.Semantic proximity Read ↗

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.Semantic proximity Read ↗

Drug-induced Brugada syndrome by noncardiac agents.Semantic proximity Read ↗

Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.Semantic proximity Read ↗

Drug‐ and non‐drug‐associated QT interval prolongationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.